CVS · 10-Q · 2026Q3 · Full report

Legacy Litigation Charges

CVS HEALTH Corp · 2026-11-04 · Importance 30 · Surprise 42

CVS Health recorded $1.2 billion in legacy litigation charges in the nine months ended September 30, 2025, related to two court decisions associated with its past business practices. The charges were reflected in operating expenses within the Pharmacy & Consumer Wellness and Health Services segments. The company reported that these charges were absent in the comparable 2026 period.

Key facts

• CVS Health recorded $1.2 billion in legacy litigation charges in the first nine months of 2025 related to two court decisions associated with its past business practices. source
• The prior-year $320 million opioid litigation charge reflected a change in CVS Health's accrual for ongoing opioid litigation matters. source
• The prior-year legacy litigation charges were reflected in Pharmacy & Consumer Wellness and Health Services operating expenses. source